1. Academic Validation
  2. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli

Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli

  • Protein Expr Purif. 2002 Aug;25(3):481-7. doi: 10.1016/s1046-5928(02)00026-8.
Ana Paula de Mattos Arêas 1 Maria Leonor Sarno de Oliveira Celso Raul Romero Ramos Maria Elisabete Sbrogio-Almeida Isaías Raw Paulo Lee Ho
Affiliations

Affiliation

  • 1 Centro de Biotecnologia, Instituto Butantan, Av. Vital Brasil 1500, 05503-900 São Paulo, SP, Brazil.
Abstract

Cholera toxin B subunit (CTB) has been extensively studied as immunogen, Adjuvant, and oral tolerance inductor depending on the antigen conjugated or coadministered. It has been already expressed in several Bacterial and yeast systems. In this study, we synthesized a versatile gene coding a 6XHis-tagged CTB (359bp). The sequence was designed according to codon usage of Escherichia coli, Lactobacillus casei, and Salmonella typhimurium. The gene assembly was based on a polymerase chain reaction, in which the polymerase extends DNA fragments from a pool of overlapping Oligonucleotides. The synthetic gene was amplified, cloned, and expressed in E. coli in an insoluble form, reaching levels about 13 mg of purified active pentameric rCTB per liter of induced culture. Western blot and ELISA analyses showed that recombinant CTB is strongly and specifically recognized by polyclonal Antibodies against the cholera toxin. The ability to form the functional pentamers was observed in Cell Culture by the inhibition of cholera toxin activity on Y1 adrenal cells in the presence of recombinant CTB. The 6XHis-tagged CTB provides a simple way to obtain functional CTB through Ni(2+)-charged resin after refolding and also free of possible CTA contaminants as in the case of CTB obtained from Vibrio cholerae cultures.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P0294
    99.88%, Peptide